Latest Publications

Share:

Preliminary Injunction Agreement Balances CDPAP Transition and Consumer Care

Following Judge Frederic Block's March 31, 2025, issuance of a temporary restraining order (TRO) temporarily halting New York state's push to consolidate the Consumer Directed Personal Assistance Program (CDPAP) under a...more

New York Court Strikes Down CDPAP Reimbursement Changes

In a significant development for fiscal intermediaries (FIs) and the Consumer Directed Personal Assistance Program (CDPAP), a New York Supreme Court Justice ruled on March 20, 2025, that the New York State Department of...more

New York Poised to Transform Health Data Privacy

New York lawmakers have passed a groundbreaking health privacy bill, the New York Health Information Privacy Act (NYHIPA or the Act), which could significantly redefine how entities handle health-related data. The Act, which...more

Proposed Bill Aims to Resolve CDPAP Controversies and Address Critical Concerns in New York

A new bill was introduced in the New York State Senate last week in an attempt to address recent changes made to the Consumer Directed Personal Assistance Program (CDPAP), which effective April 1, 2025, will allow only a...more

CDPAP Legal Storm Continues: New Lawsuit Targets DOH's RFP Implementation, Single FI Structure

A second lawsuit has been filed challenging recent changes to New York's Consumer Directed Personal Assistance Program (CDPAP or the Program), this time taking aim at the new single fiscal intermediary (FI) structure that...more

Fiscal Intermediaries Sue NYDOH Over CDPAP Reimbursement Changes

A group of fiscal intermediaries (FIs) on July 22, 2024, filed a lawsuit against the New York State Department of Health (DOH) and its commissioner, Dr. James McDonald, alleging that the defendants disregarded established...more

FDA's Final Rule on Laboratory Developed Tests Comes with Controversy and Concerns

The U.S. Food and Drug Administration's (FDA) recent announcement of a final rule extending regulatory oversight to laboratory developed tests (LDTs) has sparked controversy. As discussed in a previous Holland & Knight alert,...more

7 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide